Mythic Therapeutics

Mythic Therapeutics has developed a series of antibody-drug conjugates (ADCs) designed to demonstrate unparalleled therapeutic index and efficacy. The company's FateControl technology specifically enhances ADC uptake in target tissues by manipulating the intracellular fate of ADCs, thereby expanding the range of diseases and patient profiles that can be treated with Mythic ADCs.